Developing immunotherapy for autoimmune diseases
The Inserm Foundation is home to the Institut hospitalo-universitaire Immun4Cure in Montpellier, which has been accredited by the French government as part of France 2030.
IHU4Cure missions
The Institut Hospitalo-Universitaire (IHU) Immun4Cure is dedicated to systemic autoimmune diseases, which represent a major public health challenge. These diseases result from dysfunctions of the immune system. Immun4Cure aims to achieve a better understanding of these pathologies, earlier detection and the development of innovative treatments such as precision immunotherapies and RNA technologies. Patients will benefit from cutting-edge medical analyses and personalized clinical trials.
In May 2023, the Immun4Cure project, shared by Montpellier University Hospital, Inserm and the University of Montpellier, was awarded the Institut Hospitalo-Universitaire (IHU) label as part of the France 2030 plan.
In concrete terms, Immun4Cure’s scientific project aims to :
- A better understanding of three key diseases in particular, linked to immune system runaway – rheumatoid arthritis, scleroderma and lupus.
- Improve early detection of these diseases and optimize care paths for patients.
- Develop personalized biotherapies to treat and cure these diseases.
Key public health figures
5 à 8%
of the world's population are affected by autoimmune diseases. They represent the 2ᵉ cause of chronic pain.
Testimonial
“Supported by the Inserm Foundation, which plays an essential role, our ambition is to become Europe’s leading center for research and development in immunotherapy applied to autoimmune diseases. Thanks to its support and expertise, we can devote ourselves fully to carrying out our research, innovating in more effective treatments, coordinating the care pathway for patients and improving quality of life.”
Professor Christian Jorgensen, Director of IHU Immun4Cure
Fondation abritante : a structuring framework for philanthropic projects
The Inserm Foundation was chosen to host the Immun4Cure IHU. It plays a key role by directly supporting the management and administration of the project, while also acting as coordinating institution for the Agence Nationale de la Recherche, which is responsible for funding this initiative of excellence supported by the IHU.
The IHU Immu4cure in Montpellier offers the following advantages:
- Direct support in the budgetary, financial and operational management of the project;
- The Inserm Foundation’s image and commitment to the IHU in its search for sponsors and donors;
- Tax benefits and a secure legal framework for donations and sponsorships;
- Expert support.
“The Immun4Cure IHU represents a major step forward in scientific and medical research. Under the direction of Professor Christian Jorgensen, this ambitious project explores new avenues of research into the understanding and treatment of immune diseases. Its innovative approach, combining fundamental immunology and clinical applications, opens up promising prospects for improving the health of millions of people worldwide. Supporting the Immun4Cure IHU means investing in the future of medicine and cutting-edge therapeutic solutions.
Professor Alain Fischer – Chairman of the IHU Management Board